Cited by 42Dementia and Cognitive Impairment ResearchTreatment of Major DepressionAging, Health, and Disability

Temporal Lobe Atrophy and White Matter Lesions are Related to Major Depression over 5 years in the Elderly

Open access
Olesen, Pernille J, Gustafson, Deborah R, Simoni, Michela, Pantoni, Leonardo, Östling, Svante, Guo, Xinxin, Skoog, Ingmar·2010·Neuropsychopharmacology

Abstract

The influence of organic brain changes on the development of depression in the elderly is uncertain. Cross-sectional studies, most often from clinical samples, report associations with brain atrophy and cerebrovascular disease, while longitudinal population studies have given mixed results. Our aim was to investigate whether cortical atrophy and white matter lesions (WMLs) on computed tomography (CT) predict occurrence of depression in the elderly. This is a prospective population-based study with 5-year follow-up. The baseline sample included 525 elderly subjects, aged 70-86 years, without dementia or major depression, with a score on the Mini-Mental State Examination above 25, and without dementia at follow-up. Cortical atrophy and WMLs were evaluated at baseline using CT. The main outcome measure was development of major or minor depression at follow-up according to Diagnostic and Statistical Manual of Mental Disorders, fourth edition, as evaluated using neuropsychiatric examinations and hospital discharge registers. Logistic regression was used to estimate risk. Over the period of 5 years, 20 individuals developed major and 63 minor depression. Presence of temporal lobe atrophy (odds ratio (OR)=2.81, 95% confidence interval (CI) 1.04-7.62) and moderate-to-severe WMLs (OR=3.21, 95% CI 1.00-10.26) independently predicted major, but not minor, depression after controlling for various confounders. Other brain changes did not predict occurrence of depression. Our findings suggest that temporal lobe atrophy and WMLs represent relatively independent and complementary pathways to major depression in the elderly. This may have implications for prevention, as both neurodegeneration and cerebrovascular disease have been related to preventable factors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2010.176

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. American Psychiatric Association 1987Diagnostic and Statistical Manual of Mental Disorders3rd edn, revisedAmerican Psychiatric Association: Washington, DC [Google Scholar]
  2. American Psychiatric Association 1994Diagnostic and Statistical Manual of Mental Disorders4th ednAmerican Psychiatric Press: Washington, DC [Google Scholar]
  3. World Health Organization . The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization: Geneva; 1993. [Google Scholar]

Cited by

Sorted by citations

Authors
Olesen, P. J., Gustafson, D. R., Simoni, M., Pantoni, L., Östling, S., Guo, X., & Skoog, I.
Affiliations
  • University of Gothenburg (SE)
  • University of Florence (IT)
Corresponding author
Olesen, Pernille J
Venue
Neuropsychopharmacology
Published
2010-09-29
Volume
35
Issue
13
Pages
2638-2645
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2052149529
Cited by
42
References
50
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 5 · 2016: 5 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 1
FWCI
2.41
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Florence Research (University of Florence) (submittedVersion)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Funders
  • Alzheimer's Association (2008-1229, ZEN‐01‐3151, IIRG‐00‐2159)
  • European Commission (211696)
  • Forskningsrådet för Arbetsliv och Socialvetenskap (2006‐1506, 2006-0596, ZEN-01-3151, 2006-0020, 2008-1229, 2004-0150, IIRG-00-2159, 2001-2835, 2008-1111)
  • Fredrik och Ingrid Thurings Stiftelse
  • Vetenskapsrådet (2007–7,462, 11267, 825–2007–7462)
  • Riksbankens Jubileumsfond
  • Göteborgs Universitet
  • Swedish Brain Power (11267)
  • National Institutes of Health (5r03ag026098-02)
  • National Institute on Aging (5R03AG026098)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
Keywords
temporal lobe atrophy, white matter lesions, major depressive disorder, older adults, cortical atrophy, cerebrovascular disease, neurodegeneration, depression risk prediction, neuroimaging, depression prevention
MeSH terms
Aged, Aged, 80 and over, Atrophy, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Male, Nerve Fibers, Myelinated, Prospective Studies, Temporal Lobe, Time Factors, Tomography, X-Ray Computed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review